Rating History for Merrimack Pharmaceuticals (MACK) by Guggenheim

More Stocks Rated by Guggenheim | Latest Ratings for MACK
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/13/2015 N/A New Coverage Buy
(N/A)		 15.00
(N/A)		 11.52
(15.13)		 31.34% Details